CAN:s bibliotek

*000      am a        a
*00117249
*007cr |||||||||||
*008070120s1994||||xxu||||es|||||||||1|eng||
*1101 $aCollege on Problems of Drug dependence. Scientific Meeting (55 : 1993 : Toronto)
*24510$aProblems of drug dependence, 1993 :$bproceedings of the 55th Annual Scientific Meeting : the College on Problems of Drug Dependence, Inc.$pVol. 1 : Plenary session symposia and annual reports . - 1994. - 292 s. : ill. - (NIDA research monograph series ; 140)(NIH publication ; 94-3748) $pVol. 2 : Abstracts. - 1994. - 520 s. : ill. - (NIDA research monograph series ; 141)(NIH publication ; 94-3749)
*260  $aRockville, Md :$bNational Institute on Drug Abuse,$c1994
*300  $a2 vol.
*490  $aNIDA research monograph series ; $v140-141
*490  $aNIH publication ; $v94-3748,  94-3749
*500  $aE-bok
*520  $aI. Opioid receptors: molecular and structural studies. Teratogenicity of the drugs of abuse. Cannabinoid receptors: pharmacology, second messenger systems and endogenous ligands. Innovative approaches to drug abuse treatment. The role of excitatory amino acids in the actions of abused drugs. Tolerance and sensitization to opioids and cocaine. Antisocial personality and treatment response in substance abusers. Cardiovascular effects of cocaine: underlying mechanisms. Drugs of abuse and immunosuppression. Hallucinogenic agents: drugs of abuse as neurochemical tools. Behavioral, pharmacologic and neurobiologic variables important to the analysis of drug self administration. II. Oral communication. Psychological and social treatments. Behavioral pharmacology of cocaine and other stimulants. Behavioral pharmacology, human. Pathophysiological consequences of drug abuse. Epidemiology and sociology. Medicinal chemistry. Diagnosis, assessment and symptomatology. HIV/AIDS. Behavioral pharmacology, animal. Clinical pharmacology. Behavioral pharmacology of opioids. Molecular pharmacology. Biochemical pharmacology of opioids. Perinatal effects of drugs. Pharmacology/physiology. Biochemical pharmacology of cocaine. Analgesia . Pharmacological treatment.
*650 4$aReceptors, opioid
*650 4$aCannabinoids
*650 4$aNarcotic dependence
*650 4$aRehabilitation
*650 4$aReceptors, N-methyl-D-aspartate
*650 4$aCocaine
*650 4$aNarcotics
*650 4$aAntisocial personality disorder
*650 4$aCardiovascular system
*650 4$aResearch
*650 4$aImmunosuppression
*650 4$aHallucinogens
*650 4$aSelf administration
*650 4$aCongresses
*650 4$aAbnormalities, drug-induced
*653  $aReceptorer
*653  $aOpiater
*653  $aCannabis
*653  $aKokain
*653  $aHallucinogener
*7001 $aHarris, Louis S.$eed.
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://archives.drugabuse.gov/sites/default/files/monograph141.pdf$zVol 141
*85640$uhttps://archives.drugabuse.gov/sites/default/files/monograph140.pdf$zVol 140
^